Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Learn which cash back cards offer the best deals and rewards. Make the most of your spending with these top choices.
27,977 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Uniswap activated its fee switch today, enabling on-chain UNI buybacks funded by protocol fees. The move links revenu...
Two popular real estate ETFs take different paths: one tracks U.S. REITs, the other spans international real estate. ...
Chewy rode a brighter sales outlook to a rally in its stock, with the company signaling durable demand for pet care d...
When a metropolitan bank director sells shares, it catches the eye of investors. This article explains insider filing...
If SpaceX goes public with enough float, it may land in Vanguard-friendly CRSP-based ETFs. This guide breaks down wha...
In a landmark ruling, the supreme court overturns trump’s broad tariffs imposed under IEEPA, signaling a major check ...
SpaceX rockets higher after announcing a $60 billion all-stock purchase of Cursor AI, lifting its market cap above $2...
I’m a fan of Costco as a retailer, but my investing stance is stubbornly conservative. Here’s the core reason haven't...
SpaceX is not publicly traded, but exposure can hide in retirement funds. Analysts say large mutual funds and 401(k) ...
Institutional players are accelerating tokenization and on-chain strategies, even as many traditional investors lag b...
Charles Schwab is partnering with Cboe to launch S&P 500 yes-or-no binary options, a first-of-its-kind move into pred...